Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia

PHASE4CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

June 30, 2006

Conditions
Post-Herpetic Neuralgia
Interventions
DRUG

pregabalin

Trial Locations (40)

Unknown

Pfizer Investigational Site, Phoenix

Pfizer Investigational Site, Little Rock

Pfizer Investigational Site, Duarte

Pfizer Investigational Site, Denver

Pfizer Investigational Site, Palm Beach Gardens

Pfizer Investigational Site, Oak Brook

Pfizer Investigational Site, Flowood

Pfizer Investigational Site, St Louis

Pfizer Investigational Site, Toledo

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Allentown

Pfizer Investigational Site, Houston

Pfizer Investigational Site, Seattle

Pfizer Investigational Site, Madison

Pfizer Investigational Site, Berlin

Pfizer Investigational Site, Bochum

Pfizer Investigational Site, Düsseldorf

Pfizer Investigational Site, Frankfurt

Pfizer Investigational Site, Göppingen

Pfizer Investigational Site, Hamburg

Pfizer Investigational Site, Hattingen

Pfizer Investigational Site, Jena

Pfizer Investigational Site, Nuremberg

Pfizer Investigational Site, Wiesbaden

Pfizer Investigational Site, L’Aquila

Pfizer Investigational Site, Perugia

Pfizer Investigational Site, Pisa

Pfizer Investigational Site, Roma

Pfizer Investigational Site, Leganés

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Granada

Pfizer Investigational Site, Salamanca

Pfizer Investigational Site, Seville

Pfizer Investigational Site, Valencia

Pfizer Investigational Site, Middlesbrough

Pfizer Investigational Site, Addlestone

Pfizer Investigational Site, Chicester

Pfizer Investigational Site, Glasgow

Pfizer Investigational Site, Oldham, Lancashire

Pfizer Investigational Site, Portsmouth

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00159666 - Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia | Biotech Hunter | Biotech Hunter